Concepedia

Publication | Closed Access

Phase II study of docetaxel plus cisplatin as a second-line combined therapy in patients with advanced gastric carcinoma.

31

Citations

0

References

2005

Year

Abstract

This combination therapy was effective as a second-line treatment for advanced gastric cancer with acceptable toxic side-effects.